TY - JOUR
T1 - The transcription factor STAT6 mediates direct repression of inflammatory enhancers and limits activation of alternatively polarized macrophages
AU - Czimmerer, Zsolt
AU - Daniel, Bence
AU - Horvath, Attila
AU - Ruckerl, Dominik
AU - Nagy, Gergely
AU - Kiss, Mate
AU - Peloquin, Matthew
AU - Budai, Marietta M
AU - Cuaranta-Monroy, Ixchelt
AU - Steiner, Laszlo
AU - Nagy Jr, Bela
AU - Poliska, Szilard
AU - Banko, Csaba
AU - Bacso, Zsolt
AU - Schulman, Ira G
AU - Sauer, Sascha
AU - Deleuze, Jean François
AU - Allen, Judith
AU - Benko, Szilvia
AU - Nagy, László
N1 - Funding Information:
We thank Ms. Cseh, Szalka, Kriston, and Beladi for technical assistance and Dr. Szatmari and members of the Nagy laboratory for discussions and comments on the manuscript. This work was supported by the Hungarian Scientific Research Fund ( K100196 , K111941 , and K116855 to L.N. and K109429 to S.B.) and by SBP Medical Discovery Institute to L.N. Library preparation and bioinformatic analysis were performed at the Genomic Medicine and Bioinformatic Core Facility of the University of Debrecen. RNA sequencing was performed at the Centre National de Genotypage (CNG) Evry, by S. McGinn, A. Boland, D. Lechner, and M.T. Bihoreau and supported by the European Sequencing and Genotyping Infrastructure (funded by the European Commission , FP7/2007-2013 ) under no. 26205 (ESGI) to L.N., and also at the Analytical Genomics Core Facility at the SBP. Z.C. was supported by funding from the European Union , the European Social Fund , and the State of Hungary ( TÁMOP 4.2.4. A/2-11-1-2012-0001 “National Excellence Program” ), B.D. by the American Heart Association (AHA) postdoctoral fellowship ( 17POST33660450 ), J.E.A. by the Medical Research Council UK ( MR/K01207X/1 ), S.B. by a Bolyai and a Szodoray Postdoctoral Fellowship , and M.M.B. by the ÚNKP-17-4 New National Excellence Program of the Ministry of Human Capacities . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2017 The Authors
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/1/16
Y1 - 2018/1/16
N2 - The molecular basis of signal-dependent transcriptional activation has been extensively studied in macrophage polarization, but our understanding remains limited regarding the molecular determinants of repression. Here we show that IL-4-activated STAT6 transcription factor is required for the direct transcriptional repression of a large number of genes during in vitro and in vivo alternative macrophage polarization. Repression results in decreased lineage-determining transcription factor, p300, and RNA polymerase II binding followed by reduced enhancer RNA expression, H3K27 acetylation, and chromatin accessibility. The repressor function of STAT6 is HDAC3 dependent on a subset of IL-4-repressed genes. In addition, STAT6-repressed enhancers show extensive overlap with the NF-κB p65 cistrome and exhibit decreased responsiveness to lipopolysaccharide after IL-4 stimulus on a subset of genes. As a consequence, macrophages exhibit diminished inflammasome activation, decreased IL-1β production, and pyroptosis. Thus, the IL-4-STAT6 signaling pathway establishes an alternative polarization-specific epigenenomic signature resulting in dampened macrophage responsiveness to inflammatory stimuli. The molecular bases of repressive transcriptional mechanisms contributing to macrophage polarization are not well understood. Czimmerer et al. show that in alternatively polarized macrophages, IL-4-activated STAT6 represses a large set of enhancers modulating the transcriptional program. STAT6-repressed enhancers are characterized by reduced chromatin accessibility, eRNA expression, LDTF, and p300 binding. IL-4-STAT6-mediated repression limits the inflammatory responsiveness including inflammasome activation, IL-1β production, and pyroptosis. Thus, the IL4-STAT6 pathway establishes an epigenomic signature to selectively repress the macrophage inflammation program.
AB - The molecular basis of signal-dependent transcriptional activation has been extensively studied in macrophage polarization, but our understanding remains limited regarding the molecular determinants of repression. Here we show that IL-4-activated STAT6 transcription factor is required for the direct transcriptional repression of a large number of genes during in vitro and in vivo alternative macrophage polarization. Repression results in decreased lineage-determining transcription factor, p300, and RNA polymerase II binding followed by reduced enhancer RNA expression, H3K27 acetylation, and chromatin accessibility. The repressor function of STAT6 is HDAC3 dependent on a subset of IL-4-repressed genes. In addition, STAT6-repressed enhancers show extensive overlap with the NF-κB p65 cistrome and exhibit decreased responsiveness to lipopolysaccharide after IL-4 stimulus on a subset of genes. As a consequence, macrophages exhibit diminished inflammasome activation, decreased IL-1β production, and pyroptosis. Thus, the IL-4-STAT6 signaling pathway establishes an alternative polarization-specific epigenenomic signature resulting in dampened macrophage responsiveness to inflammatory stimuli. The molecular bases of repressive transcriptional mechanisms contributing to macrophage polarization are not well understood. Czimmerer et al. show that in alternatively polarized macrophages, IL-4-activated STAT6 represses a large set of enhancers modulating the transcriptional program. STAT6-repressed enhancers are characterized by reduced chromatin accessibility, eRNA expression, LDTF, and p300 binding. IL-4-STAT6-mediated repression limits the inflammatory responsiveness including inflammasome activation, IL-1β production, and pyroptosis. Thus, the IL4-STAT6 pathway establishes an epigenomic signature to selectively repress the macrophage inflammation program.
KW - IL-1β
KW - IL-4
KW - STAT6
KW - alternative macrophage polarization
KW - inflammasome activation
KW - inflammation
KW - macrophage epigenomics
KW - pyroptosis
KW - repression
KW - transcription
U2 - 10.1016/j.immuni.2017.12.010
DO - 10.1016/j.immuni.2017.12.010
M3 - Article
C2 - 29343442
SN - 1074-7613
VL - 48
SP - 0
JO - Immunity
JF - Immunity
IS - 1
ER -